Log in

NASDAQ:MTBC - Medical Transcription Billing Stock Price, Forecast & News

$5.50
-0.03 (-0.54 %)
(As of 04/1/2020 07:30 AM ET)
Today's Range
$5.39
Now: $5.50
$5.86
50-Day Range
$3.89
MA: $5.66
$7.59
52-Week Range
$3.25
Now: $5.50
$7.75
Volume82,084 shs
Average Volume273,467 shs
Market Capitalization$67.87 million
P/E RatioN/A
Dividend YieldN/A
Beta1.45
Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company's offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform. PracticePro includes practice management software and related tools, which facilitate the day-to-day operation of a medical practice; electronic health records (EHR), which allow its customers to qualify for government incentives; revenue cycle management (RCM) services, which include medical billing, analytics and related services, and mobile Health (mHealth) solutions, including smartphone applications that assist patients and healthcare providers in the provision of healthcare services. The Company offers a clearinghouse service, which allows clients to track claim status.
Read More
Medical Transcription Billing logo

Industry, Sector and Symbol

Industry Prepackaged software
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:MTBC
CUSIPN/A
Phone732-873-5133

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$64.44 million
Cash Flow$0.33 per share
Book Value$3.51 per share

Profitability

Net Income$-870,000.00

Miscellaneous

Employees2,700
Market Cap$67.87 million
Next Earnings Date5/13/2020 (Estimated)
OptionableNot Optionable

Receive MTBC News and Ratings via Email

Sign-up to receive the latest news and ratings for MTBC and its competitors with MarketBeat's FREE daily newsletter.


Medical Transcription Billing (NASDAQ:MTBC) Frequently Asked Questions

How has Medical Transcription Billing's stock been impacted by COVID-19 (Coronavirus)?

Medical Transcription Billing's stock was trading at $5.31 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MTBC shares have increased by 3.6% and is now trading at $5.50. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Medical Transcription Billing?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medical Transcription Billing in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Medical Transcription Billing.

When is Medical Transcription Billing's next earnings date?

Medical Transcription Billing is scheduled to release its next quarterly earnings announcement on Wednesday, May 13th 2020. View our earnings forecast for Medical Transcription Billing.

How were Medical Transcription Billing's earnings last quarter?

Medical Transcription Billing Corp (NASDAQ:MTBC) posted its earnings results on Friday, February, 28th. The technology company reported ($0.12) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by $0.06. The technology company earned $15.76 million during the quarter, compared to analysts' expectations of $16.05 million. Medical Transcription Billing had a negative return on equity of 6.22% and a negative net margin of 3.66%. View Medical Transcription Billing's earnings history.

What guidance has Medical Transcription Billing issued on next quarter's earnings?

Medical Transcription Billing updated its FY 2020 Pre-Market earnings guidance on Friday, February, 28th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $100-102 million, compared to the consensus revenue estimate of $100.4 million.

What price target have analysts set for MTBC?

3 brokers have issued 1 year target prices for Medical Transcription Billing's shares. Their forecasts range from $6.00 to $6.25. On average, they expect Medical Transcription Billing's share price to reach $6.08 in the next twelve months. This suggests a possible upside of 10.6% from the stock's current price. View analysts' price targets for Medical Transcription Billing.

Has Medical Transcription Billing been receiving favorable news coverage?

Media coverage about MTBC stock has trended very negative recently, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Medical Transcription Billing earned a coverage optimism score of -3.0 on InfoTrie's scale. They also assigned press coverage about the technology company a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near future. View the latest news aboutMedical Transcription Billing.

Are investors shorting Medical Transcription Billing?

Medical Transcription Billing saw a increase in short interest during the month of February. As of February 28th, there was short interest totaling 41,300 shares, an increase of 27.9% from the February 13th total of 32,300 shares. Based on an average daily trading volume, of 134,100 shares, the short-interest ratio is currently 0.3 days. Currently, 0.6% of the shares of the stock are short sold. View Medical Transcription Billing's Current Options Chain.

Who are some of Medical Transcription Billing's key competitors?

What other stocks do shareholders of Medical Transcription Billing own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medical Transcription Billing investors own include BlackBerry (BB), NVIDIA (NVDA), Verastem (VSTM), Micron Technology (MU), Sophiris Bio (SPHS), AbbVie (ABBV), Alibaba Group (BABA), Advanced Micro Devices (AMD), Microbot Medical (MBOT) and Etsy (ETSY).

What is Medical Transcription Billing's stock symbol?

Medical Transcription Billing trades on the NASDAQ under the ticker symbol "MTBC."

How do I buy shares of Medical Transcription Billing?

Shares of MTBC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Medical Transcription Billing's stock price today?

One share of MTBC stock can currently be purchased for approximately $5.50.

How big of a company is Medical Transcription Billing?

Medical Transcription Billing has a market capitalization of $67.87 million and generates $64.44 million in revenue each year. The technology company earns $-870,000.00 in net income (profit) each year or ($0.60) on an earnings per share basis. Medical Transcription Billing employs 2,700 workers across the globe. View additional information about Medical Transcription Billing.

What is Medical Transcription Billing's official website?

The official website for Medical Transcription Billing is http://www.mtbc.com/.

How can I contact Medical Transcription Billing?

Medical Transcription Billing's mailing address is 7 CLYDE ROAD, SOMERSET NJ, 08873. The technology company can be reached via phone at 732-873-5133.


MarketBeat Community Rating for Medical Transcription Billing (NASDAQ MTBC)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  235 (Vote Outperform)
Underperform Votes:  225 (Vote Underperform)
Total Votes:  460
MarketBeat's community ratings are surveys of what our community members think about Medical Transcription Billing and other stocks. Vote "Outperform" if you believe MTBC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MTBC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel